1Sem.·

Merck & Co. exciting opportunity or underestimated risk?

Hello everyone,

I am currently looking at $MRK (+2,28 %) and am considering adding the share to my portfolio. The company is known as a pharmaceutical giant with a strong drug portfolio, especially thanks to Keytruda, which is one of the best-selling cancer drugs worldwide. The pipeline seems promising, the dividend solid and the company has proven in recent years that it remains stable despite market uncertainties.

Nevertheless, there are also risks: patent expiries, competition from biosimilars and possible regulations could slow down growth. The valuation is quite attractive in historical terms.

I am interested in your opinion:

Do you see Merck as a strong buy-and-hold stock or do the risks outweigh the risks for you? How do you assess the growth potential vs. the challenges?

I look forward to your opinions!

8 Commentaires

Fabian@d4Y

1Sem.

I think in the pharma sector you should always bet on a few different, fundamentally good stocks with a good history and therefore also potential for the future...
You never know exactly what will happen.
That's why, for me, Merck also belongs in the portfolio.

•

Giuse@Coyote980

1Sem.

@d4Y I agree ...at the moment with a savings plan

••

Michael@Neverloosemoney

1Sem.

I am well invested and will remain so

•

MHi_292@Valueformoney

1Sem.

I'm also thinking about getting in, and I also see Merck as a solid medium-term investment. As the share is currently on a downward trend, I will wait and see.

•

market_expert_gbtws@market_expert_gbtws

1Sem.

I'm in it big time, good opportunity, great dividend and certainly higher prices in the long term

•

Robert@AktienRobert

1Sem.

I bought Merk, think the share is currently fairly valued

••

An@wealth_navigator_15

1Sem.

I have a similar view. The share has potential and is currently valued at a low level. Unless I have overlooked something.
Fundamentally, the company is in a good position.
Outlook for 2025 is not so great. China market a small risk, as the main market is in the US, but justifiable.
Companies usually adapt to new regulations.

••

mami_goes_boerse@mami_goes_boerse

I also bought Merck a few days ago. I also see the company as stable.

••